- Home
- LEGN vs DLB Comparison
LEGN vs DLB Comparison
Compare LEGN & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- DLB
- Stock Information
- Founded
- LEGN 2014
- DLB 1965
- Country
- LEGN United States
- DLB United States
- Employees
- LEGN N/A
- DLB N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- DLB Multi-Sector Companies
- Sector
- LEGN Health Care
- DLB Miscellaneous
- Exchange
- LEGN Nasdaq
- DLB Nasdaq
- Market Cap
- LEGN 7.0B
- DLB 7.9B
- IPO Year
- LEGN 2020
- DLB 2005
- Fundamental
- Price
- LEGN $28.33
- DLB $75.74
- Analyst Decision
- LEGN Strong Buy
- DLB Strong Buy
- Analyst Count
- LEGN 13
- DLB 4
- Target Price
- LEGN $75.67
- DLB $101.75
- AVG Volume (30 Days)
- LEGN 1.6M
- DLB 384.8K
- Earning Date
- LEGN 05-13-2025
- DLB 05-01-2025
- Dividend Yield
- LEGN N/A
- DLB 1.74%
- EPS Growth
- LEGN N/A
- DLB 36.08
- EPS
- LEGN N/A
- DLB 2.64
- Revenue
- LEGN $728,303,000.00
- DLB $1,320,184,000.00
- Revenue This Year
- LEGN $64.21
- DLB $6.38
- Revenue Next Year
- LEGN $53.69
- DLB $4.65
- P/E Ratio
- LEGN N/A
- DLB $28.82
- Revenue Growth
- LEGN 112.46
- DLB 4.03
- 52 Week Low
- LEGN $27.34
- DLB $66.35
- 52 Week High
- LEGN $60.87
- DLB $89.66
- Technical
- Relative Strength Index (RSI)
- LEGN 36.81
- DLB 48.04
- Support Level
- LEGN $27.34
- DLB $76.69
- Resistance Level
- LEGN $33.30
- DLB $77.59
- Average True Range (ATR)
- LEGN 1.91
- DLB 1.26
- MACD
- LEGN -0.30
- DLB 0.20
- Stochastic Oscillator
- LEGN 13.51
- DLB 57.08
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About DLB Dolby Laboratories
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.